Evotec SE (NAS:EVO)
$ 4.54 -0.34 (-6.97%) Market Cap: 1.61 Bil Enterprise Value: 1.77 Bil PE Ratio: 0 PB Ratio: 1.56 GF Score: 73/100

Q3 2019 Evotec SE Earnings Call Transcript

Nov 12, 2019 / 01:00PM GMT
Release Date Price: $10.78 (+1.08%)
Operator

Dear ladies and gentlemen, welcome to the conference call of Evotec AG. At our customers' request, this conference will be recorded. (Operator Instructions)

May I now hand you over to Dr. Werner Lanthaler, who will lead you through this conference. Please go ahead, sir.

Werner Lanthaler
Evotec SE - CEO & Member of Management Board

Welcome to our Q3 analyst call. Winning the race for new drug requires strong partners to come together. Evotec is providing the autobahn, where innovation and efficiency meet. With this, welcome again. We have uploaded a presentation for this Q3 call, which is available on the Internet. And on this presentation, you can follow this conference call.

My name is Werner, I'm here together with my team, which you see on Page #2 of this presentation. Enno Spillner, our CFO; Craig Johnstone, our COO; and Cord Dohrmann, our CSO. Building and expanding this autobahn brings us together under the vision of Evotec. Research never stops until all diseases are curable.

If you go to Page #4 of this presentation,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot